SCHEMBL22425354

SCHEMBL22425354

Cc1cccc([C@H]2COCCN2)c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRKACA P17612 1/20 0.52
PRKACG P22612 1/20 0.52
PRKACB P22694 1/20 0.52
HTR2C P28335 4/20 0.46
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
MAP4K1 Q92918 2/20 0.39
CYP19A1 P11511 1/20 0.38
CTSK P43235 1/20 0.38
ALOX15 P16050 2/20 0.37
ALOX12 P18054 2/20 0.37
ALOX15B O15296 1/20 0.37
HTR2B P41595 2/20 0.36
SLC6A3 Q01959 2/20 0.36
HTR2A P28223 2/20 0.36
SLC6A4 P31645 1/20 0.36
NPC1 O15118 1/20 0.36
HPN P05981 1/20 0.36
SLC6A2 P23975 1/20 0.36
ADRA1A P35348 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22425356 1.00 PRKACA (0.52) PRKACAPRKACGPRKACBHTR2CMEN1
SCHEMBL30370083 0.83 HTR2C (0.45) PRKACAPRKACGPRKACBHTR2CMEN1
SCHEMBL27758952 0.83 PRKACA (0.41) PRKACAPRKACGPRKACBMAP4K1CTSK
SCHEMBL7353494 0.81 PRKACA (0.52) PRKACAPRKACGPRKACBHTR2CMEN1
SCHEMBL432870 0.81 PRKACA (0.52) PRKACAPRKACGPRKACBHTR2CMAP4K1
SCHEMBL14839631 0.81 PRKACA (0.52) PRKACAPRKACGPRKACBHTR2CCTSK
SCHEMBL21723230 0.81 PRKACA (0.52) PRKACAPRKACGPRKACBHTR2CMEN1
SCHEMBL30824548 0.81 PRKACA (0.52) PRKACAPRKACGPRKACBHTR2CMAP4K1
SCHEMBL28785154 0.81 PRKACA (0.52) PRKACAPRKACGPRKACBHTR2CMAP4K1
SCHEMBL28028671 0.81 PRKACA (0.59) PRKACAPRKACGPRKACBMAP4K1CTSK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220162191-A1 SMALL MOLECULE MODULATORS OF IL-17 LEO PHARMA A/S (DK) 2022-05-26 US disclosed
WO-2020182666-A1 SMALL MOLECULE MODULATORS OF IL-17 LEO PHARMA A/S (DK) 2020-09-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220162191-A1 SMALL MOLECULE MODULATORS OF IL-17 IL17A, IL15, IL2 PRKACA 282/4885PRKACG 283/4885PRKACB 368/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.